.svg){kind=small}
Aug-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kikoko has demonstrated varying performance across different categories in California. In the Beverage category, the brand has shown a slight improvement, moving from the 20th position in June 2024 to the 16th position in August 2024. This positive trend indicates a growing acceptance and popularity of Kikoko's beverages among consumers. On the other hand, the Edible category performance was less consistent, with the brand barely making it into the top 30 in July 2024 and then slipping back to the 31st position in August 2024. This indicates potential challenges in maintaining a strong foothold in the competitive edible market.
In the Capsules category, Kikoko has exhibited strong and relatively stable performance. The brand consistently ranked within the top 5, peaking at the 3rd position in June and July 2024 before slightly dropping to the 4th position in August 2024. This consistent ranking underscores Kikoko's strength and reliability in the capsules market within California. However, the brand's absence from the top 30 in some categories highlights areas where it may need to focus on improving its market presence and product offerings to capture a larger consumer base.
Competitive Landscape
In the competitive landscape of the California cannabis capsules market, Kikoko has shown notable fluctuations in rank and sales over the past few months. In May 2024, Kikoko was ranked 5th but saw an improvement to 3rd place in June and July, before slipping back to 4th in August. This indicates a competitive but volatile position within the market. Kikoko's sales peaked in July at $820,096, reflecting a strong performance, but slightly declined to $797,181 in August. In comparison, Breez consistently held the 2nd rank with sales significantly higher, peaking at $1,412,368 in August. ABX / AbsoluteXtracts also showed a strong upward trend, moving from 4th to 3rd place with sales increasing to $807,560 in August. Meanwhile, Emerald Bay Extracts experienced a decline, dropping from 3rd to 5th place, with sales decreasing to $494,732 in August. This competitive analysis highlights Kikoko's resilient yet competitive positioning, suggesting opportunities for strategic initiatives to regain and sustain higher rankings.
Notable Products
In August 2024, the top-performing product from Kikoko was the XTabs - Sativa High Dose Tablets 20-Pack (1000mg) in the Capsules category, maintaining its number one rank from the previous month with sales of 6864 units. The XTabs - Indica High Dose Tablets 20-Pack (1000mg) also held steady at the second position, showing a slight increase in sales to 6733 units. The XTabs - Hybrid High Dose Tablets 20-Pack (1000mg) consistently ranked third throughout the months, with August sales reaching 5372 units. The Little Helpers - CBN/THC/Melatonin 3:2 Sleep Mints 20-Pack (60mg CBN, 40mg THC, 20mg Melatonin) remained in fourth place, showing stable sales performance. Notably, the Little Helpers - CBD/THC 2:1 Calm Mints 20-Pack (100mg CBD, 50mg THC) re-entered the rankings in fifth place with sales of 958 units, having previously been unranked in June and July.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
